Late complaints after erythema migrans

 Late complaints after erythema migrans Herta Klade, MD and Elizabeth Aberer, MD. JSTD 
1994; 1:52-56.
A lot of treatment studies have been carried out, but no antibiotic has been proved to avoid late 
manifestations of Lyme disease. Our interest focused on late manifestations 
following20uncomplicated erythema migrans, UEM, and complicated erythema migrans, CEM, 
after a median observation period of 30 months. To compare the therapeutic, serological, and 
clinical outcome, 161 patients were re-examined prospectively. Late complaints could be 
observed in 31/161, 19%, of patients, more often in CEM than in UEM, 36% versus 12%. 
Patients with late sequelae were more often seropositive than the total collective, 77% versus 67%, 
at least once during the observation period, as against 12 of 13 patients who needed several 
therapy cycles, 92%. Seven seropositive patients did not respond to oral antibiotic treatment 
even after several cycles. Amoxicillin/clavulanic acid treated patients had late complaints in 8% 
in contrast to penicillin V, 15%, and doxycycline, 17%, treated persons.
Seropositivity before treatment has a negative influence on the course of erythema migrans, EM, 
disease. Immunogenetic disposition might be responsible for repeated infections and for 
treatment failures in a certain patient group




Share This
Pin on PinterestShare on FacebookTweet about this on TwitterShare on StumbleUponShare on Google+

Leave a Reply

Your email address will not be published.